GlyNAC improves multiple defects in aging to boost strength and cognition in older humans

Mental health support at boarding schools helps only male students feel safe from bullying
29 March 2021
SARS-CoV-2 positivity in asymptomatic-screened dental patients
29 March 2021

GlyNAC improves multiple defects in aging to boost strength and cognition in older humans

A pilot human clinical trial conducted by researchers at Baylor College of Medicine reveals that supplementation with GlyNAC—a combination of glycine and N-acetylcysteine as precursors of the natural antioxidant glutathione—could improve many age-associated defects in older humans to improve muscle strength and cognition, and promote healthy aging.

Comments are closed.